Rome IV Criteria-Defined Irritable Bowel Syndrome in Atopic Patients and the Effect of Anxiety and Depression: A Case-Control Study.

BACKGROUND: Numerous studies report an increased prevalence of irritable bowel syndrome in patients with atopic diseases such as allergic rhinitis, allergic asthma, and chronic urticaria. Both disease groups have a higher incidence of psychological disorders. In this study, we aimed to examine the relationship of irritable bowel syndrome with the presence and severity of allergic diseases and accom- panying anxiety and depression. METHODS: One hundred sixty-two patients (56 with AR, 34 with AA, and 72 with CU) and 43 healthy volunteers were included in the study. Demographic and clinical data, along with disease duration and severity, was analyzed. Irritable bowel syndrome was diagnosed using Rome IV criteria. Hospital Anxiety and Depression Scale was used to evaluate anxiety and depression. All statistical analyses were performed using Statistic Program for Social Sciences 23.0. RESULTS: Irritable bowel syndrome prevalence in the control group was 9.3% and 56% in atopic patients (P < .0001). Hospital Anxiety and Depression Scale anxiety scores of 11 and above increased the odds of IBS approximately 14 times, and independently, the presence of allergic disease increased the odds 10 times. In the allergic patient subgroup, Hospital Anxiety and Depression Scale anxiety scores of 11 and above increased the risk of irritable bowel syndrome approximately 18 times. CONCLUSION: In this first study using Rome IV criteria to examine the relationship of irritable bowel syndrome, allergic diseases, and anxiety and depression, irritable bowel syndrome was more frequent in allergic patients, especially in patients with anxiety. Awareness of a disease cluster where these 3 disease groups intersect will guide clinicians from different disciplines involved in patients' treatment and follow-up.

An analysis of scientometric data and publication policies of rheumatology journals.

OBJECTIVE: Scientometric indexes, based on citations, may be increased by open access (OA) publishing. We aimed to present the scientometric data of of rheumatology journals and analyze the scientometric data of rheumatology journals according to the OA publication policy. METHOD: Scientometric indexes and bibliometric data of 22 journals were obtained from Clarivate Analytics InCites, Scopus, and Scimago Journal & Country Rank websites. We included journal impact factor (JIF), CiteScore (CS), Hirsch index (HI), Source Normalized Impact per Paper (SNIP), Eigenfactor score (ES), and Scientific Journal Ranking (SJR). We separated the OA publishing policies into full OA and hybrid OA. The US dollar (USD) was used as the requested fee unit. RESULTS: All pairs of scientometric indexes had positive significant correlations. However, a journal in the first quartile of JIF was observed in the second quartile of CS, SNIP, and SJR, and the last quartile of ES and HI. Scientometric indexes of of full and hybrid OA journals were similar, apart from HI, which was higher in hybrid OA journals (p = 0.03, Mann-Whitney U test). However, full OA journal fees were less expensive by a median of 935 USD (p = 0.007, Mann-Whitney U test). CONCLUSION: We recommend that the JIF and HI pair or the ES paired with CS or SNIP be used together to evaluate rheumatology journals. We failed to show that the OA model positively affects the scientometric indexes of rheumatology journals; our results contradict the literature reporting that the OA publication model causes an increase in citations. Key Points •Clinicians should understand the scientometric indexes in rheumatology and if open access publishing affects citations (therefore, scientometric indexes). •The JIF and HI pair or the ES paired with CS or SNIP can be used to express different rankings since they are based on different databases and use different calculation methods. •We show that OA publication does not affect citations or scientometric indexes of rheumatology journals. •When choosing a rheumatology journal to publish OA, rheumatologists should consider individual OA citation patterns and APC charges together.

Scientometric Data and Open Access Publication Policies of Clinical Allergy and Immunology Journals.

Introduction The scientific merit of a paper and its ability to reach broader audiences is essential for scientific impact. Thus, scientific merit measurements are made by scientometric indexes, and journals are increasingly using published papers as open access (OA). In this study, we present the scientometric data for journals published in clinical allergy and immunology and compare the scientometric data of journals in terms of their all-OA and hybrid-OA publication policies. Methods Data were obtained from Clarivate Analytics InCites, Scimago Journal & Country Rank, and journal websites. A total of 35 journals were evaluated for bibliometric data, journal impact factor (JIF), scientific journal ranking (SJR), Eigenfactor score (ES), and Hirsch index (h-index). US dollars (USD) were used for the requested article publishing charge (APC). Results The most common publication policy was hybrid-OA (n = 20). The median OA publishing APC was 3000 USD. Hybrid-OA journals charged a higher APC than all-OA journals (3570 USD vs. 675 USD, p = 0.0001). Very strong positive correlations were observed between SJR and JIF and between ES and h-index. All the journals in the h-index and ES first quartiles were hybrid-OA journals. Conclusion Based on these results, we recommend the use of SJR and ES together to evaluate journals in clinical allergy and immunology. Although there is a wide APC gap between all-OA and hybrid-OA journals, all journals within the first quartiles for h-index and ES were hybrid-OA. Our results conflict with the literature stating that the OA publication model's usage causes an increase in citation counts.